Focus Rheums| ACR Convergence 2024 Previews

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Related Articles

    Judge Signals Skepticism in Trump Team’s Bid to Block Obamacare Suit

    (Reuters)—A U.S. judge signaled skepticism on Wednesday toward a bid by President Donald Trump’s administration to block a lawsuit by the state of Maryland seeking to preserve the Obamacare law in a case that also challenges Trump’s appointment of Matthew Whitaker as acting attorney general. At a nearly three-hour hearing in federal court in Baltimore,…

    Maryland Judge to Weigh Obamacare Case

    (Reuters)—Days after a judge in Texas declared that the Obamacare healthcare law is unconstitutional, Maryland’s Democratic attorney general on Wednesday will pursue his request that another judge rule the opposite way. The lawsuit brought by Maryland Attorney General Brian Frosh also seeks to challenge President Donald Trump’s appointment of Matthew Whitaker as acting attorney general,…

    Maryland Lawmakers Approve Bill to Fight Drug Price-Gouging

    WASHINGTON (Reuters)—Maryland lawmakers have passed a first-in-the-nation measure that lets the state attorney general sue generic drugmakers that sharply raise prices in a move aimed at fighting what legislators call “price-gouging.” The bill overwhelmingly was approved by the Democratic-controlled legislature on Monday and hailed by Maryland Attorney General Brian Frosh as a way to check…

    Drug Industry on Tenterhooks as Maryland Price-Gouging Law Nears

    (Reuters)—As U.S. consumer outrage grows over prescription drug prices, state authorities and patient advocates in Maryland are preparing to enforce the nation’s first law designed to punish drugmaker price-gouging. The Maryland Attorney General’s office said it will field complaints and investigate “unconscionable increases” in essential generic medicines when the closely watched law takes effect Oct….